Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
Snap Shares Edge Up in Premarket Amid Texas Lawsuit and Insider Sale
Snap stock rose 0.3% premarket following a 4.6% decline, as Texas sues over child safety allegations and co-founder files to sell 1 million shares. Analyst firm Arete upgraded the stock to Buy.
Applied Materials Settles $252M China Export Case, Shares Dip Ahead of Earnings
Applied Materials shares edged lower premarket after agreeing to a $252.5 million settlement over unauthorized chip equipment exports to China. The company reports quarterly results after the close.
NovoCure Shares Surge on FDA Approval for Pancreatic Cancer Device
NovoCure's stock jumped over 20% premarket after the FDA cleared its Optune Pax device for treating locally advanced pancreatic cancer, marking the first new treatment for this condition in nearly three decades.
IRS Direct Deposit Errors Could Delay 2026 Tax Refunds, Agency Warns
The IRS cautions that incorrect bank details may freeze refunds this filing season, urging taxpayers to verify information and use electronic tools for faster processing.
Kyndryl Shares Rally Amid Internal Review and Outlook Reset
Kyndryl Holdings saw its shares climb approximately 9% in after-hours trading, extending a recovery from a sharp decline earlier in the week. The IT services provider is navigating a delayed quarterly filing and an internal audit committee review of its financial controls.
Lockheed Martin Shares Hold Steady Amid Pentagon Contractor Review
Lockheed Martin shares traded near $630 as the Pentagon initiates an extended review of major defense contractors, potentially impacting shareholder returns. CEO and CFO are scheduled to speak at a Citi conference next week.
Hims & Hers Shares Stabilize After Novo Nordisk Patent Lawsuit Rattles Weight-Loss Strategy
Hims & Hers stock edged up 0.1% premarket following steep declines after Novo Nordisk filed a patent lawsuit over compounded semaglutide. Investors await court developments, FDA signals, and the company's Feb. 23 earnings.
IRS Warns 2026 Tax Refund Delays Likely Without Accurate Direct Deposit Details
The IRS cautions that missing or incorrect bank information will hold 2026 refunds, with updates only accepted by mail. Most e-filed refunds arrive within 21 days, but delays could extend into March.
Tax Season 2026: Key Deadlines, Refund Timelines, and Penalty Warnings
The IRS sets April 15, 2026 as the federal filing deadline for 2025 returns, with extensions available until October. Most refunds arrive within 21 days, but some credits may delay payments until March.
GSK's RSV Vaccine Advances in Chinese Regulatory Review, Eyes 2027 Decision
GSK's Arexvy RSV vaccine application has been accepted for review by China's drug regulator, with a potential approval decision expected in 2027. The stock edged higher as JPMorgan raised its price target and the company's dividend ex-date approaches.
Meta Shares Dip Amid Regulatory Pressure in Germany and India
Meta Platforms stock declined roughly 1% in after-hours trading following a German court ruling ordering a €30 million payment to Deutsche Telekom and India's new three-hour content removal mandate.
